Tony Sk Mok

25PUBLICATIONS
168CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsiesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Apr 10, 2026
First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.

Jhanelle E Gray, Joel W Neal, Jyoti D Patel

|Mar 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Jian-Chun Duan, Jia Zhong, Bo-Yang Sun

|Feb 02, 2026
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

Zhe Huang, Liang Zeng, Zhaohui Ruan

|Dec 08, 2025
Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood.

Yang Xia, Yin Zhu, Sai Zhang

|Apr 29, 2025
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial.

Byoung Chul Cho, Shun Lu, Myung Ah Lee

|Mar 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.

Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro

Pageof 5

Frequent Collaborators

6 joint publications

Yi-Long Wu

6 joint publications

Byoung Chul Cho

4 joint publications

Solange Peters

3 joint publications

Benjamin J Solomon